cold-1284028_1920_edited.jpg

Developing Effective Local Treatments

for Urinary Tract  Diseases

Our Mission

Trigone Pharma is dedicated to developing safe and effective local treatments for urinary tract diseases.

 

Our first product in development addresses the unmet need for efficient and localized treatment of Interstitial Cystitis / Bladder Pain Syndrome (IC/BPS). This chronic bladder condition causes recurring bouts of pain and pressure in the bladder and pelvic area, often accompanied by an urgent and frequent need to urinate.  

 

Trigone Pharma's product is designed to provide longer exposure of the urinary tract tissue to medications. It enables localized therapy to be a highly effective treatment option by increasing the sustained release of drugs and dwell time in the bladder for safe therapeutic effect and improved patient compliance. Our product integrates well-established regulatory compliant components that present effective, safe, easy-to-handle, and user-friendly treatment administration at 1-4 weeks intervals. 

 

Our Pipeline

01.

IC/BPS

02.

Over Active Bladder

03.

Renal Colic

04.

Bladder Cancer

© 2020 by Trigone Pharma

15 HaTidhar Street, Raanana, Israel

Email :dan.t@trigonepharma.com

Tel: +972-9-7403336